As expected, inhibition of AKT/eNOS or blockade of sGC in vitro reversed the inhibitory effect of S1pr1‐overexpressing EC‐conditioned medium on fibroblast migration, proliferation and myofibroblasts activation, explaining the molecular mechanism by which EC‐S1pr1 prevents heart failure development. The gene discussed is S1PR1; the disease is heart failure.